@olsonplanner It’s close, but not quite. Strength has the strongest correlation with longevity. Muscle mass has a strong correlation too, but is likely a surrogate of strength.
@olsonplanner Tyler, I think it would be super helpful if you did a thread geared towards trainees moonlighting: how to deal with 1099 income from a tax standpoint, financial priorities that may now be attainable with extra income, records to keep, and how this income may affect IDR plans.
@olsonplanner For some reason, mine now says payments don’t start until 5/2024, but the estimated payment is much higher than what it should be based on income and family size. Any thoughts on why this may be?
@TrevAlberts Incredibly excited for you, Trev. We will be praying for you and your family as you make this move and in your new position. May you be the man in leadership that so many young men and women need.
Congratulations to one of the DeRoin Memorial Scholarship recipients, Garret Dockweiler (UNMC, M4). Mr. Dockweiler and his wife would like to move to a small town in Nebraska after graduation. The NAFP is excited to watch Mr. Dockweiler's Family Medicine experience!
The latest CDC #COVIDView shows that people 65+ have the highest rates of COVID-19 hospitalizations. Protect people most at risk for serious illness by taking the recommended actions to slow the spread of #COVID19. Learn how you can help: https://t.co/DmfPOAPMjW.
NEW Case Series: First detailed reports on 10 patients in northern Italy describes increase in rare inflammatory condition in young children, a Kawasaki-like disease, since the #COVID19 pandemic arose in the Lombardy region https://t.co/EuWpXaADqf
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19): https://t.co/35qY7fp9pJ via @JAMA_current#CHESTCritCare#COVID19
Endothelial cell infection found in vessels of COVID-19 patients post mortem. Can this explain the macrovascular complications seen in COVID-19? https://t.co/yWdKHT2613
This study showed no increase in likelihood of a positive Covid-19 test or severe Covid-19 in patients taking any of 5 common classes of antihypertensive drugs. #COVID19#SARSCoV2
This population-based case-control study from northern Italy shows that ACE inhibitor and ARB use was more frequent among patients with Covid-19 due to a higher prevalence of cardiovascular disease. There was no evidence that ACE inhibitors and ARBs affected risk of #COVID19.
#Casereport: a pregnant woman with symptomatic #coronavirus disease who experienced a second-trimester miscarriage in association with documented placental #SARSCoV2 infection #COVID19 https://t.co/5nGcrX8owO
As deaths from #coronavirus disease 2019 continue to mount, desperation has driven physicians to try therapies backed by little or no evidence. @RitaRubin reports on the use of #convalescentplasma against #COVID19 https://t.co/Lb7dNOHZP9
NEW—An alarming rise in incidence of infective endocarditis in England since 2009: why? Martin H Thornhill, Mark J Dayer, Jon Nicholl, et al, discuss in a Comment https://t.co/mZBmYchVWa
"We all are working diligently and swiftly to do the science in the appropriate way to help in this pandemic. It also gives us hope that soon this drug may be used widely."
- Dr. Kalil, a professor of infectious diseases in the UNMC Department of Internal Medicine